THE J HEALTHCARE INITIATIVE
Methylfentanyls
Found in:
Fentanyl
Type/Reason added:
Fentanyl Analog
Relative Potency:
α-methylfentanyl:
similar to fentanyl, but more toxic (11)
(+)-cis-3-methylfentanyl: 20 times stronger than fentanyl
(-)-cis-3-methylfentanyl: about 20% of fentanyl (11)
(±)-trans-3-methylfentanyl:
similar to fentanyl (11)
Treatment Options
Supportive Care:
Airway management and assisted ventilation, supplemental oxygen to correct hypoxia, cardiac monitoring and IV fluid administration to stabilize blood pressure and heart rate.
Antidote:
Naloxone, an opioid antagonist. Given their potency and long duration of action, multiple doses or a continuous naloxone infusion may be necessary.
Pharmacokinetics and Dynamics
Metabolism:
Mainly metabolized in the liver by CYP3A4. Some will undergo metabolism via CYP 3A5, CYP 2D6, CYP 2C19. Phase II glucuronic acid conjugates are also detected for hydroxylated metabolites.
Drug-Drug Interactions:
Methylfentanyls interact dangerously with other central nervous system depressants such as alcohol, benzodiazepines, and other opioids. These combinations drastically increase the risk of respiratory depression, coma, and death.
Speak with the professionals
You are not alone, we are here to help.
Feel free to connect with nearby professionals to help what you need.
Don’t worry. We’re here to help.
686868
Chat to support